Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Emergent BioSolutions
Sort By
Newest First
1 / 1
1 / 1
COVID-19 Vaccine Manufacturing
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate
Emergent Biosolutions
PR-M07-20-NI-007
Jul 07, 2020
Capacity Expansion
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability
Emergent Biosolutions
PR-M06-20-NI-029
Jun 23, 2020
Biotechnology
CMO Services Built on a Culture of Agility
Emergent Biosolutions
PTV-M08-19-BIO-006
Aug 12, 2019
Fill/Finish
Fill/Finish: Increasing Investment and Flexibility for Effective Manufacturing
B.J. Hull
Emergent Biosolutions
PAP-Q1-2019-CL-029
Mar 12, 2019
Announcement
Baltimore Biotech Earns International Recognition for Advanced Development and Manufacturing Facility
Emergent Biosolutions
PR-M01-19-NI-020
Jan 04, 2019
Acquisition
Emergent BioSolutions to Acquire PaxVax from Cerberus Capital Management
PaxVax
PR-M08-18-NI-114
Aug 30, 2018
Acquisition
Emergent BioSolutions Expands Its Drug Portfolio Through Two Acquisitions
Emilie Branch
Pharma's Almanac
PAO-M07-17-NI-030
Jul 25, 2017
